Mail & Guardian
Mail & Guardian
antiretroviral drugslatest news & developments
What’s the best way to spend the HIV prevention budget so that the country can drive infections down as fast as possible? We take a look at what modelling data shows. (Pexels, kaboompics)

180 000 infections in 2024, 47 000 by 2045 — if SA rolls out the twice-a-year HIV prevention jab fast enough

The HIV prevention shot, lenacapavir, will be rolled out at South African clinics within the next couple of months and from 2027, the health department will also buy generics.…

South Africa’s first consignment of lenacapavir (LEN), the twice-yearly anti-HIV injection, arrived at OR Tambo International Airport last week. Photo: Mufid Majnun/Unsplash

SA’s first batch of LEN jabs will arrive in February. Use Bhekisisa’s dashboard to find out who should get them

Who should get what slice of the pie once the medicine is available in public clinics? And are numbers alone what would drive decisions?

According to a survey, 85% of managers reported that their clinics faced staffing shortages, though only one in five blamed these on the US President’s Emergency Plan For Aids Relief cuts

Clinics short-staffed after Pepfar funding cuts

According to a survey, 85% of managers reported that their clinics faced staffing shortages, though only one in five blamed these on the US President’s Emergency Plan For Aids…

Two Indian generic drugmakers — Hetero and Dr Reddy’s — will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot around R692 per person per year. (Anna-Maria van Niekerk)

Two drugmakers will sell the 6-monthly anti-HIV jab for the price of the daily prevention pill

Hetero and Dr Reddy’s will be funded by the Gates Foundation and Unitaid to produce and sell the twice-a-year anti-HIV shot around R692 per person a year

Dr June Fabian, Director of the Wits Donald Gordon Medical Research Institute at Wits.

The renal revolutionary

From silent killer to centre stage, Dr June Fabian is spotlighting kidney disease in Africa

Dolutegravir was initially dubbed a wonder drug but a small possible risk of birth defects stalled a global rollout. South Africa has put strict monitoring in place to catch any potential defects early.

Risks & benefits: new HIV drug combo could change the course of SA’s epidemic

South Africa’s next chapter in HIV treatment holds amazing promise, but unlocking it rests on having the right kind of discussions with women

(John McCann/M&G)

The quest for the (vaginal) ring

The HIV prevention tablet is now available in South Africa but popping a pill every day to stay HIV-negative may not be for everyone

There is a silent nostalgia for Mbeki to return to the country’s mainstream political discourse. (Oupa Nkosi/M&G)

Mark Heywood: ‘I was pitched against the very government I had fought for’

Activists litigated to force government to give HIV-positive people antiretrovirals. Mia Malan talks to Mark Heywood about the political consequences

South Africa may still need donor support to fund expanded ARV roll out in the country.

Exposed: Southern African trio ‘sold expired ARVs’ in Europe at a 4 000% markup

Life-saving HIV drugs were allegedly diverted from Africa’s public health system to sell in Europe.

#AIDS2016: Five things African journalists want to know from Bill Gates

Bill Gates was at the International Aids Conference this week. He spent time with five African journalists. Here is what they wanted to know.

Knowing your HIV status could curb the spread of the virus

#AIDS2016: From medical circumcision to vaccines, these seven things will change HIV

We know more than ever about how to prevent HIV infection, including what may someday lead to the world’s first HIV vaccine.

Patients are still forced to pay out of their own pockets for ARVs

#AIDS2016: ​HIV may be a prescribed benefit, but not all medical schemes cover ARVs

In theory medical aids fund ARVs, but in practice it’s a complex process, say doctors and activists.

Johannes Phokela at his Selby

SA makes great strides in treating ‘strong’ TB

The country has one of the highest tuberculosis burdens. But it is rapidly gaining access to new diagnostic tools and medicine for drug-resistant TB.

Free ARVs are not enough: The hidden costs of treating HIV in Nigeria

Financial risk-protection mechanisms could alleviate the high food and transport costs incurred by rural people seeking to access treatment for HIV.

Truvada – the pre-exposure prophylaxis.

SA registers a two-in-one pill that can prevent HIV infection

South Africa has become only the second country in the world to allow widespread access to groundbreaking HIV pre-exposure prophylaxis medication.

Antiretrovirals

Malawi ARVs traded on Jozi’s streets

Health workers steal drugs that are bought by smugglers and sold to fearful "illegal" foreigners.

Malawi ARVs traded on Jozi’s streets

Health workers steal drugs that are bought by smugglers and sold to fearful "illegal" foreigners.

SSP found that the Free State’s medicine supply was in a state of ‘provincial emergency’ after finding that all six facilities it surveyed between May and July in six sub districts experienced drug stock-outs of essential medicines.

Survey uncovers shortages in critical medication

A survey of stock levels of HIV drugs is in stark contrast to health department claims that "there is no shortage".

Health Minister Aaron Motsoaledi denies claims that there is a shortage of adequate drugs in SA.

Motsoaledi refutes claims SA faces drug shortages

The health minister says the media portrays the department as failing to provide drugs for patients, but supply is also subject to business decisions.

Vaginal gel won’t protect women against HIV

The search for an anti-HIV microbicide continues, after a new trial has refuted the results of a previous study that found one to be effective.